| One Health-st. Labre School | |
|
112 St. Labre Campus Drive Ashland MT 59003 | |
| (406) 784-2346 | |
| (406) 784-2711 |
| Full Name | One Health-st. Labre School |
|---|---|
| Speciality | Clinic/Center |
| Location | 112 St. Labre Campus Drive, Ashland, Montana |
| Authorized Official Name and Position | David Mark (CEO) |
| Authorized Official Contact | 4066654103 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| One Health-st. Labre School 10 4th St W Hardin MT 59034-1802 Ph: (406) 784-2346 | One Health-st. Labre School 112 St. Labre Campus Drive Ashland MT 59003 Ph: (406) 784-2346 |
| NPI Number | 1144680844 |
|---|---|
| Provider Enumeration Date | 02/24/2016 |
| Last Update Date | 10/20/2023 |
| Certification Date | 10/19/2023 |
| Medicare PECOS PAC ID | 8820246077 |
|---|---|
| Medicare Enrollment ID | O20180117002298 |
News Archive
Findings from a retrospective study of 1,200 women provide reassurance to breast cancer survivors who are contemplating pregnancy.
The clot-busting drug rt-PA remains the most beneficial proven emergency treatment for strokes caused by blood clots, according to an editorial in the November issue of Archives of Neurology by Dr. Jos- Biller.
Imaxio, a biopharmaceutical company specialized in vaccines, today announces that it has signed an option for a license agreement with the world-renowned German Center for Cancer Research (DKFZ – Deutsches Krebsforschungszentrum), based in Heidelberg. The financial terms of the agreement were not disclosed.
A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy -; which is limited to the skin and areas accessible with an endoscope -; this technique can target and attack cancer cells that have spread deep inside the body, according to researchers at Washington University School of Medicine in St. Louis.
New research has shed light on the complex exchange of parasitic worms between wildlife, rats and humans.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144680844 | NPI | - | NPPES |
News Archive
Findings from a retrospective study of 1,200 women provide reassurance to breast cancer survivors who are contemplating pregnancy.
The clot-busting drug rt-PA remains the most beneficial proven emergency treatment for strokes caused by blood clots, according to an editorial in the November issue of Archives of Neurology by Dr. Jos- Biller.
Imaxio, a biopharmaceutical company specialized in vaccines, today announces that it has signed an option for a license agreement with the world-renowned German Center for Cancer Research (DKFZ – Deutsches Krebsforschungszentrum), based in Heidelberg. The financial terms of the agreement were not disclosed.
A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy -; which is limited to the skin and areas accessible with an endoscope -; this technique can target and attack cancer cells that have spread deep inside the body, according to researchers at Washington University School of Medicine in St. Louis.
New research has shed light on the complex exchange of parasitic worms between wildlife, rats and humans.
› Verified 9 days ago